CannaRoyalty Corp. (OTCQX: CNNRF) is a North American cannabis consumer product company currently focused on building a leading distribution business in California, the world’s largest regulated cannabis market. By building a world-class logistics platform and supporting contract manufacturing assets, the Company intends to support the growth of new and established cannabis brands.

 

Canada is set to implement their legalization of recreational cannabis use on October 17^th. In the U.S., 30 states have some form of legal medical cannabis use and 9 states have approved recreational cannabis use along with many municipalities. In November voters will decide on ballot proposals for recreational cannabis use in Michigan and N. Dakota. Utah and Missouri voters will be deciding if they want a medical marijuana law on their books.

 

Q2 marked a turning point for CannaRoyalty, and its shareholders as the team translated strategy and execution into record financial performance. The Company generated earnings per share of $0.18 primarily by delivering on its stated objective of rationalizing early passive investments. The Company also generated a record adjusted EBITDA result for a Canadian-listed cannabis company.

 

As per management, Q2 is just the beginning of a multi-quarter parabolic step change in revenue, powered by sequential acquisitions and organic growth. CannaRoyalty generated a record $3.5 million in revenue in Q2-2018, a 446% increase from Q1 and more than the Company generated in all of 2017. These results reflect the successful initiation of the Company’s strategic focus on building its Californian distribution and brands platform.

 

This growth is expected to continue in Q3 and Q4 as FloraCal and RVR are added to the Company’s financials and as the company’ team continues to grow market share and expand the Company’s supporting manufacturing and value-add services footprint. Both RVR and FloraCal are performing above expectations, and the company is actively executing its plans to increase the revenue generating capacity of both companies.

______________________________________________________________________

Our members have booked up to 800% with our recent (2018) NASDAQ and NYSE small cap alerts. We will be initiating coverage on another exciting small cap security mid-week this week (10/14/18). View our recent picks, track record and sign up for our real time mobile/text alerts here – https://tradersnewssource.com/traders-news-source-new-members/

______________________________________________________________________

Strategic Sale/deals in the recent past and profit: As CannaRoyalty continues to grow and build a solid presence in California as a cannabis brands company and a major third-party distributor, the company’ focus has been concentrated on realizing value from assets that are non-core to the business.

 

• On October 3rd, the company announced a definitive agreement with Australis Capital Inc. whereby Australis will purchase 2,200,000 common shares in the capital of Wagner Dimas Inc. from Cannroy Delaware Inc., a wholly-owned subsidiary of CannaRoyalty. The approximately 182% return on investment from the sale of an equity stake in Wagner Dimas reinforces CNNRF’ commitment to generate significant returns for shareholders and fund accretive growth in the key markets in North America

 

• On August 27th, the company announced that it has entered into a binding letter of intent with Tidal Royalty Corp., a leading provider of royalty financing to licensed U.S. cannabis operators, whereby Tidal Royalty will acquire the Company’s equity stake and royalty entitlement in Alternative Medical Enterprises LLC (“AltMed”) for a consideration of $8 million, representing approx. 168% return on investment for CannaRoyalty’s shareholders. CannaRoyalty will maintain the right to license MÜV products in California, Nevada, Canada, and other select markets.

 

• Before this, the company sold its stake in Anandia Labs, as well as its exclusive Canadian license to Wagner Dimas’s pre-roll technology to Aurora Cannabis for a combined value of $26 million. These transactions represent a combined return of approx. 500% on the investments and will enable the company to continue to execute its growth plans while repurchasing shares.

 

The outlook for 2018 & 2019: The company is expected to exit 2018 at a significantly higher quarterly revenue run rate than CannaRoyalty’s record rate of Q2. Thus, the market is extremely bullish about the upcoming Q3 and Q4 results to see the revenue generating power of this business moving into 2019.

 

Analyst tracking the stock and the industry believes that the cannabis market is positioned for strong growth pending further market legalization and California, home to some of the world’s most discerning consumers and a nexus of information and trends, will be the point of inception for the global cannabis brands of the future.

 

The Company’s leadership and staff combine passion and a hands-on understanding of the cannabis industry, with proven financial and legal expertise. Considering all this, the company is in an extremely favorable risk-reward position, and value investors should consider exposure in this sector as the backdrop remains exceptionally favorable.

 

 

About the Company: CannaRoyalty is a North American cannabis consumer product company currently focused on building a leading distribution business in California, the world’s largest regulated cannabis market. By building a world-class logistics platform and supporting contract manufacturing assets, the Company intends to support the growth of new and established cannabis brands.  CannaRoyalty’s shares trade on the Canadian Stock Exchange (CSE) under the symbol CRZ and in the US on the OTCQX under the symbol CNNRF.

 

Portfolio: CannaRoyalty has developed a diversified portfolio of assets within the cannabis sector, including research, infrastructure, and intellectual property to support its existing brands, partner products, and distribution networks.

 

Brands in Distribution – California

Owned & Licensed Brands in California

 

Other recent announcements:

• CannaRoyalty to Present at U.S. Cannabis Symposium in Toronto on October 18, 2018. The one-day event will feature company presentations and one-on-one meetings with industry leaders who will discuss the opportunities and challenges of the U.S. cannabis market
• Trichome Financial Corp. Announces Proposed Qualifying Transaction with 22 Capital Corp.
• The company has signed a binding term sheet to acquire 100% of investee 180 Smoke and its affiliates for total consideration of $25 million, as well as an additional $15 million upon the completion of certain milestones.
• 420 Wellness, a subsidiary of investee 180 Smoke, has been approved by the City of Calgary to open its first cannabis dispensary in the city, pending approval from the Alberta Gaming and Liquor Commission.

 

Industry Potential:

• As per a research by Genesis Market Insights, the worldwide cannabis industry was valued at USD 17.18 Billion in 2017 and is likely to surpass USD 58 Billion by 2023. This is primarily led by increasing legalization of medical and recreational and cannabis.

 

Second Quarter 2018 Financial Results – All comparisons below are to June 30, 2017, unless otherwise noted

• Revenues were $3.5 million as compared to $960,157, an increase of 266%;
• Gross margin was $820,935 as compared $421,681, an increase of 95%;
• Net income of $9.3 million as compared to a net loss of $2.0 million;
• Net income per basic share of $0.18 as compared to a net loss per basic share of $0.05;

• Cash was $15.7 million as compared to $4.5 million an increase of 248%;
• Total assets of $94.8 million as compared to $46.1 million, an increase of 105%;
• Current assets of $23.5 million as compared to $7.9 million, an increase of 196%;
• Current liabilities of $5.9 million as compared to $2.1 million, an increase of 178%; and
• Long-term debt of $290,457 as compared to $2.3 million, a decrease of 87%.

 

Key risk factors and potential stock drivers:

• CNNRF is on the verge of seeing meaningful results from their current investments. Analysts remain hopeful that these payoffs will take shape quite soon and remain bullish about the stock price.
• CNNRF is still an early stage company and is yet to demonstrate a stable track record of growing revenue and profitability. Therefore, its ability to maintain liquidity and financial flexibility to fund its incremental capital requirements will remain a challenge for the company.
• Continuing growth in the cannabis sector could act as a catalyst for the company shares.
• Notwithstanding recent positive developments, Marijuana remains illegal under federal law. It is a Schedule I controlled substance. Even in those jurisdictions in which the use of medical marijuana has been legalized at the state level, its prescription is a violation of federal law.

 

Stock Performance

 

Comments:

• On Monday, October 15th, 2018, CNNRF was at $5.80, on volume of 172K shares exchanging hands. Market capitalization is $333.24 million. The current RSI is 60.28
• In the past 52 weeks, shares of CNNRF have traded as low as $1.83 and as high as $23.36
• At $5.80, shares of CNNRF are trading above its 50-day moving average (MA) at $4.75 and above its 200-day moving average (MA) at $3.82
• The present support and resistance levels for the stock are at $5.3846 & $5.7646 respectively.

 

 

Disclaimer

Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.

Traders News Source has not been compensated for this report by anyone and the opinions if any are that of the author Vikas Agrawal, CFA. Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I, wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article.

This web site, published by TNS LLC, and is an investment newsletter that is built on the premise of assisting individual investors in learning about investing. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers. TNS LLC does not give buy or sell recommendations. We do purchase distribution rights from analyst, financial writers and bloggers for a fee that may be licensed to issue price targets and recommendations. Furthermore, we encourage you to speak to a licensed professional prior to making an investment in any type of publicly traded security.

We do sell advertising to other companies including brokerage firms, web sites, publicly traded issuers, investor relations firms, and investment publications, among others. TNS LLC makes no warranty as to the policies of these organizations, and in no way endorses their offers, services, or the content of their advertisements.

When an advertiser is a publicly traded company or a third party acting on behalf of a public company, we fully disclose all compensation in the email advertisement. Such disclosure is included in a disclosure statement in each of the advertisements sent via email.

17B Disclosure

Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.

TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur.

Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.